Spots Global Cancer Trial Database for squamous cell carcinoma of the esophagus
Every month we try and update this database with for squamous cell carcinoma of the esophagus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | NCT00006245 | Esophageal Canc... | alvocidib paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy | NCT01243398 | Adenocarcinoma ... Esophageal Canc... | quality-of-life... | 18 Years - | University of Oxford | |
| Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | NCT00258297 | Esophageal Canc... | gefitinib conventional su... enzyme inhibito... neoadjuvant the... protein tyrosin... surgery | 18 Years - | University of Rochester | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT00445861 | Esophageal Canc... | cetuximab + doc... Treatment level... Treatment level... conventional su... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT01107639 | Adenocarcinoma ... Esophageal Canc... | cetuximab cisplatin docetaxel adjuvant therap... neoadjuvant the... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | NCT01212822 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... | bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00003118 | Esophageal Canc... | cisplatin fluorouracil surgical proced... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | NCT00861094 | Esophageal Canc... | cisplatin 5-FU oxaliplatin radiation thera... Folinic Acid | 18 Years - | UNICANCER | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | NCT00238407 | Esophageal Canc... | Docetaxel and C... Radiotherapy | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer | NCT00573131 | Esophageal Canc... Adenocarcinoma ... Squamous Cell C... | OncoGel (Paclit... cisplatin 5-FU radiation thera... esophageal rese... | 18 Years - | Boston Scientific Corporation | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | NCT00093652 | Esophageal Canc... | gefitinib oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00030862 | Esophageal Canc... | cisplatin irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | NCT00002984 | Esophageal Canc... | cisplatin fluorouracil paclitaxel surgical proced... radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | NCT00006472 | Esophageal Canc... | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | - 120 Years | Medstar Health Research Institute | |
| Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00290719 | Esophageal Canc... | cisplatin gefitinib irinotecan hydr... conventional su... neoadjuvant the... radiation thera... | 18 Years - | University of California, San Francisco | |
| PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00016900 | Esophageal Canc... | liposomal pacli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy | NCT03762564 | Squamous Cell C... | Ramucirumab Paclitaxel | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00021320 | Esophageal Canc... | cisplatin fluorouracil paclitaxel conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | NCT00601692 | Esophageal Canc... | cisplatin docetaxel irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | NCT00509561 | Esophageal Canc... | cetuximab capecitabine cisplatin radiation thera... | 18 Years - | Wales Cancer Trials Unit | |
| Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery | NCT01612546 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | cyclodextrin-ba... Laboratory biom... Pharmacological... | 18 Years - | City of Hope Medical Center | |
| Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | NCT00004257 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | NCT00268437 | Esophageal Canc... | carboplatin Pemetrexed conventional su... neoadjuvant the... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | NCT00002897 | Esophageal Canc... | cisplatin fluorouracil conventional su... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00732745 | Adenocarcinoma ... Esophageal Canc... | docetaxel oxaliplatin vandetanib placebo | 18 Years - | Case Comprehensive Cancer Center | |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT01107639 | Adenocarcinoma ... Esophageal Canc... | cetuximab cisplatin docetaxel adjuvant therap... neoadjuvant the... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | NCT00425425 | Esophageal Canc... | cetuximab fluorouracil oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 70 Years | Technical University of Munich | |
| Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00069953 | Esophageal Canc... | filgrastim pegfilgrastim cisplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | NCT01212822 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... | bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer | NCT00655876 | Esophageal Canc... | cetuximab cisplatin paclitaxel radiation thera... | 18 Years - 74 Years | Radiation Therapy Oncology Group | |
| Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus | NCT00766480 | Esophageal Canc... | cisplatin fluorouracil radiation thera... | 20 Years - 74 Years | National Cancer Institute (NCI) | |
| Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | NCT01129206 | Adenocarcinoma ... Adenocarcinomas... Recurrent Esoph... Squamous Cell C... Stage IV Esopha... | pralatrexate docetaxel fludeoxyglucose... positron emissi... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | NCT00003326 | Esophageal Canc... | paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002631 | Esophageal Canc... | chemotherapy cisplatin fluorouracil low-LET electro... low-LET photon ... | 18 Years - | Radiation Therapy Oncology Group | |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT00445861 | Esophageal Canc... | cetuximab + doc... Treatment level... Treatment level... conventional su... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | NCT00005599 | Esophageal Canc... Gastric Cancer | bryostatin 1 paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer | NCT00524121 | Esophageal Canc... | erlotinib hydro... immunohistochem... radiation thera... | 65 Years - 120 Years | Roswell Park Cancer Institute | |
| Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | NCT00861094 | Esophageal Canc... | cisplatin 5-FU oxaliplatin radiation thera... Folinic Acid | 18 Years - | UNICANCER | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | NCT00009880 | Esophageal Canc... Gastric Cancer | filgrastim cisplatin fluorouracil paclitaxel radiation thera... | - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | NCT00004897 | Esophageal Canc... | recombinant int... cisplatin fluorouracil hydroxyurea leucovorin calc... conventional su... radiation thera... | - | Northwestern University | |
| Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | NCT00381706 | Esophageal Canc... | cetuximab ECF IC FOLFOX | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| A Study of KF-0210 in Advanced Solid Tumors Patients | NCT04713891 | Advanced Solid ... Colorectal Canc... Lung Cancer Squamous Cell C... Gastric Cancer Bladder Cancer | KF-0210 tablets... KF-0210 tablets... KF-0210 tablets... KF-0210 tablets... KF-0210 (dosage... KF-0210 (dosage... KF-0210 (dosage... | 18 Years - | Keythera (Suzhou) Pharmaceuticals Co. Ltd | |
| Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer | NCT00537121 | Esophageal Canc... Gastric Cancer Liver Cancer | fluorouracil irinotecan hydr... leucovorin calc... vorinostat pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | NCT00045526 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Esoph... Squamous Cell C... Stage III Esoph... Stage IV Esopha... | erlotinib hydro... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | NCT00520091 | Esophageal Canc... | CPT- 11 Cisplatin Celecoxib Radiation Surgery | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | NCT01212822 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... | bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer | NCT00268346 | Esophageal Canc... | ZD1839 | 18 Years - | Case Comprehensive Cancer Center | |
| Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | NCT00425425 | Esophageal Canc... | cetuximab fluorouracil oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 70 Years | Technical University of Munich | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | NCT00397904 | Esophageal Canc... Gastric Cancer | cetuximab cisplatin irinotecan hydr... immunohistochem... laboratory biom... biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Positron Emission Tomography in Determining Stage of Esophageal Cancer | NCT00004867 | Esophageal Canc... | conventional su... positron emissi... radionuclide im... fludeoxyglucose... chemotherapy Radiotherapy | 18 Years - | Alliance for Clinical Trials in Oncology | |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer | NCT00900094 | Breast Cancer Colorectal Canc... Esophageal Canc... Liver Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... | fluorescence in... polymerase chai... protein express... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | NCT00047112 | Esophageal Canc... | cisplatin fluorouracil conventional su... neoadjuvant the... radiation thera... | - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | NCT01129206 | Adenocarcinoma ... Adenocarcinomas... Recurrent Esoph... Squamous Cell C... Stage IV Esopha... | pralatrexate docetaxel fludeoxyglucose... positron emissi... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT01107639 | Adenocarcinoma ... Esophageal Canc... | cetuximab cisplatin docetaxel adjuvant therap... neoadjuvant the... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| A Study of KF-0210 in Advanced Solid Tumors Patients | NCT04713891 | Advanced Solid ... Colorectal Canc... Lung Cancer Squamous Cell C... Gastric Cancer Bladder Cancer | KF-0210 tablets... KF-0210 tablets... KF-0210 tablets... KF-0210 tablets... KF-0210 (dosage... KF-0210 (dosage... KF-0210 (dosage... | 18 Years - | Keythera (Suzhou) Pharmaceuticals Co. Ltd | |
| Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | NCT00509561 | Esophageal Canc... | cetuximab capecitabine cisplatin radiation thera... | 18 Years - | Wales Cancer Trials Unit | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | NCT00009880 | Esophageal Canc... Gastric Cancer | filgrastim cisplatin fluorouracil paclitaxel radiation thera... | - | Radiation Therapy Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
